eyeforpharma believes that the ultimate driver for the pharmaceutical industry’s health is meeting the needs of patients, like us, for affordable and accessible healthcare.
Change can only come when the industry recognises the real issues: we believe, the industry must focus on a model combining service as well as product, with patients at the center.
eyeforpharma is a hub for senior-level pharma executives, patient advocacy groups and other health experts to exchange ideas and stay up to date with shifting trends and practices within the pharmaceutical industry. We provide industry-focused commentary, events, reports, and other valuable expert-driven content. Our ultimate aim is to facilitate positive change through discussion and debate, enabling dialogue within the industry and driving the positive benefits that pharmaceuticals can offer. We actively respond to the aims and interests of our audience, so please get in touch if you think we can do even more.
To meet key members of the team click here.
One of eyeforpharma's biggest strengths is to be able to gather opinion directly from industry executives themselves rather than the consultants and suppliers you see forming the majority of opinions in most pharmaceutical magazines. We leverage this to provide unique features and thought-leadership, across the world. Most of this is available on this website - just use the search box to find something specific. You can also contribute your own articles and blog. If you would like to get involved contact our Editor, Craig Sharp on email@example.com.
The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of eyeforpharma. Examples of analysis performed within this article are only examples. Assumptions made within the analysis are not reflective of the position of eyeforpharma.
30% of pharma executives expect business as usual, as they admit to expecting blockbuster-type...
Lucy Brake speaks to Mike Rea, CEO of IDEA Pharma, about how he believes real world evidence...
Dr Jean-Michel Cosséry, the new UK managing director and vice president for its Northern Europe hub...